Market Analysis: Global Veterinary Clostridium Vaccine Market
The Global Veterinary Clostridium Vaccine Market is expected to rise from its initial estimated value of USD 494.65million in 2018 to an estimated value of USD 715.37 million by 2026 registering a CAGR of 4.72% in the forecast period of 2019-2026. This rise in the market can be attributed to the rising in animal adoption, increase in occurrence of injuries and diseases in animals, and the technological advancements.
Market Definition: Global Veterinary Clostridium Vaccine Market
Clostridium vaccines provides immunity against for a variety of ovine and bovine clostridial diseases such as tetanus, black disease, pulpy kidney (enterotoxaemia), and blackleg. These vaccines can inhibit clostridial disease problems in beef cattle in California. These diseases can result in the rapid death of affected cattle.
Due to the increased awareness relating to zoonotic the demand for clostridium vaccine market is increasing.
- The demand for clostridium vaccine is increasing by the increased awareness relating to zoonotic diseases and the increase occurrence rate of clostridium family diseases
- Technology advancement
- Increasing consumption of Animal-derived Products
- High cost of treatment works as a obstacle for the market growth
- Strict Regulations acting as a major market restraint
Market Segmentation: Global Veterinary Clostridium Vaccine Market
- Animal Species
- Distribution Channel
- Veterinary Clinic
- Veterinary Hospital
- Veterinary Research Institute
- Retail Pharmacy
- North America
- South America
- Rest of South America
- United Kingdom
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
- South Africa
- Saudi Arabia
- United Arab Emirates
- Rest of Middle East and Africa
- North America
Key Developments in the Market:
- In May, 2018, Zoetis acquired Abaxis, a Leading Global Provider of Veterinary Point-of-Care Diagnostic Instruments to enhance its presence in veterinary diagnostics, This will increase its presence in veterinary diagnostics approximately 10% compound annual growth over the last three years and this can also provide a new platform for growth that Zoetis can accelerate with sales of its products in more than 100 countries.
- In June, 2016, Sanofi and Boehringer Ingelheim signed an agreement Sanofi’s Animal Health and Boehringer Ingelheim’s Consumer Healthcare Business. After this acquisition, Boehringer Ingelheim becomes the second largest animal-health company and it will bethe top provider worldwide of parasiticides and vaccines for both production animals and pets.
Competitive Analysis: Global Veterinary Clostridium Vaccine Market
The global veterinary clostridium vaccine market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of veterinary clostridium vaccine market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.
Key Market Competitors: Global Veterinary Clostridium Vaccine Market
Few of the major market competitors currently working in the veterinary clostridium vaccine market are Bayer AG, Bimeda, Inc., Boehringer Ingelheim International GmbH., Ceva , Eli Lilly and Company, Intervet Inc., a subsidiary of Merck & Co. Inc., Sanofi, Virbac, Zoetis, Inc., Aratana Therapeutics, Inc., ARKO Labs, CanFel Therapeutics, CEVA Logistics, Hygieia Biological Laboratories, Nuovo Biologics,LLC, Valneva SE,.
Research Methodology: Global Veterinary Clostridium Vaccine Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or can drop down your enquiry.
The key research methodology used by DBMR Research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Demand Side: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.
Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.
Reasons to Purchase this Report:
- Current and future of global veterinary clostridium vaccine market outlook in the developed and emerging markets
- The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
- Regions/Countries that are expected to witness the fastest growth rates during the forecast period
- The latest developments, market shares, and strategies that are employed by the major market players
Customization of the Report:
- All segmentation provided above in this report is represented at country level
- All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)